Background and Objective: Leishmania major is a flagellate protozoan parasite causing cutaneous leishmaniasis. Although pentavalent antimony compounds are the firstline drugs for leishmaniasis, their application is often accompanied by numerous limitations and side effects. Therefore, it is necessary to seek drugs of herbal origin that have fast-acting benefits and few side effects without resistance. This study aimed to evaluate the in vitro effects of methanolic extract of Arctiul lappa root on promastigotes and amastigotes of L. major.
extraction. The ground A. lappa root was immersed in 80% methanol at ratio of 1:5 (m/v) in the laboratory, away from the sunlight in lidded glass jars for 72 hours. The contents of the jars were filtered through sterile gauze and filter paper. They were turned into powder in vacuum at 40°C. The extract was refrigerated in opaque glasses until used for testing. First, the powder was dissolved in saline. Then, 0.2 µl was filtered by syringe filters to determine extract dilution by filter size before the powder was applied and tested. After that, 100 µL of L. major promastigotes in logarithmic phase of the growth at density of 2 x 10 6 were added to the 96-well plates. next, 100µl of prepared concentrations of scabies extract were added to the each well, and the plate was incubated at 23±2°C. Five wells containing medium without drugs were considered as controls. All tests were repeated four times. The effects of the herbal extract on the parasites were determined after 24, 48, and 72 hours by direct method and MTT assay. First, 50 mg of MTT powder were measured and placed into a Falcon tube. Then, 10 ml of buffer (pH 7.4) were added to the tube. The tube was shaken in the dark to achieve a uniform yellow solution. The solution was filtered under cell culture hood using a 0.2 micron filter into a sterile Falcon tube wrapped completely in tinfoil and was stored in the dark until testing. Next, 100µL of L. major promastigotes in logarithmic phase was added to each well so that each well contained 2x10 6 parasites. A. lappa root extract at concentrations of 10, 100, 500, 1000 µg/ml was prepared. Then, 100 µl of Glucantime at concentrations of 10, 100, 1000, and 10000 µg/ml was added to the 96-well plates with four repetitions. Furthermore, 100 µl of medium containing parasites and 100 µl of RPMI with 10% FBS were added to five well of the plate, and then incubated for 24, 48, and 72 hours as controls. Next, 20 µl of the MTT solution (10% of each well volume, 5 mg/ml) was added to the wells after 24, 48, and 72 hours in the dark. After incubation for four hours at 23°C, 100 µl of dimethyl sulfoxide (DMSO) solution was added to each well. Formazan crystals dissolved after 15 to 30 minutes, and a purple color was observed. Optical density (OD) of the wells was read at the wavelength of 570 nm using an ELISA
INTRODUCTION
Leishmaniasis is a complex disease shared between humans and animals, caused by the protozoan Leishmania. It is prevalent in 88 countries and considered a common problem in tropical and subtropical regions, with 1.5 million new cases reported every year. Cutaneous leishmaniasis is divided into urban (dry) and rural (wet) forms depending on the clinical manifestations. Sand flies in the genus Phlebotomus are vectors of the disease (1, 2) . Pentavalent antimony compounds are considered first-line drugs in the treatment of cutaneous leishmaniasis. However, the use of these drugs have some disadvantages such as unavailability, high cost, painful injection into the wound, treatment duration, severe toxic effects on the heart and kidneys, recurrence of the disease, scarring, and drug resistance (3, 4, 5) . Therefore, it is necessary to find herbal alternatives for these pharmaceutical compounds. Arctium lappa is a medicinal plant belonging to the Asteraceae family. The main constituents of this plant are five powerful flavonoids, terpenoids, inulin, several polyphenols, tannins and polyactylene (6) . Roots of A. lappa have numerous therapeutic effects, and have been used in traditional medicine for treatment of arthritis, myelination, eczema, acne, and dysphasia (7) . Pharmacological studies and clinical trials also indicated that burdock roots have antiinflammatory, free radical scavenging, antioxidant, anti-tumor, anti-viral, anti-bacterial, anti-fungal, cytotoxic and genotoxic activities (8) (9) (10) (11) (12) (13) (14) (15) (16) . Due to the fewer side effects associated with herbal compounds compared to chemical agents, the effect of methanolic extract of A. lappa root was evaluated in this study.
MATERIAL AND METHODS
An Iranian strain of Leishmania major (MRHO/IR/75/ER) was used in this study. The parasites were acquired from the Department of Parasitology of Razi Institute and cultivated in RPMI 1640 medium with 10% FBS (its complement was disabled at 56°C for 30 minutes) at 23 ± 2 °C. A. lappa was collected from Fandegloo region in Ardabil. After verification by a botanist, the aerial parts were cleaned, and the roots were shadow-dried. The roots were crushed, grounded and drenched in methanol for sterile conditions. Then, 200 µl of the tube contents containing 10 4 macrophages and 200 µl of L. major promastigotes at stationary phase were added to each well to infect the macrophages. Overall, 10 5 parasites were present in each well. After incubation at 37°C and 5% CO 2 for 24 hours (0r parasite/macrophage ratio of 10.1), a sterile sampler was used to remove the contents of plates containing un-adhered macrophages and parasites that did not penetrate into the macrophages. The RPMI 1640 medium and 10% FBS were added to the plates. The plates were investigated under inverted microscope to ensure that macrophages were infected ( Figure 1 ) (17) . After that, 200 µl of A. lappa root extract with concentrations of 500 and 1000 µg/ml was added to each well. In addition, 1000 and 10,000 µg/ml of Glucantime were added to each well, with four repetition. Each 5-ml ampoule of glucantime® contained 1.5 g meglumine antimoniate corresponding to 0.405 g of pentavalent antimony (Sanofi-Aventis, France). The two control wells only contained infected macrophages. Round lamellas were removed from the bottom of the 12-well plate after 24 and 48 hours of incubation at 37 °C. They were fixed with pure methanol and then stained by Giemsa. The number of amastigotes inside the macrophages was counted under a microscope using the 100x (oil immersion) objective lens, and the results were presented as percentages. [log(x2)-log(x1)]. Seceral 4-week-old BALB/C mice (due to their sensitivity to Leishmania) were euthanized with ether in a desiccator under sterile conditions. The mice were immersed in 70% alcohol and then placed on an expanded polystyrene foam. Abdominal skin was lifted using sterile forceps and notched with scissors in a longitudinal line without creating a hole in the peritoneum. Then, 5ml of sterile PBS solution (pH 7.4) was injected under the mouse's peritoneum by a syringe without contact with animal offal. Peritoneum fluid was collected by syringe in a 15cc sterile Falcon tube and centrifuged for 10 min at 1500 rpm. The contents of the tube were discarded under the hood and the sediment was washed with PBS. After discarding the supernatant, 4 ml of RPMI 1640 medium was added to the macrophages deposited. Finally, 20 µl of the fluid was removed, and cells were counted with a Neobar slide (17, 18) . Cell cultures and round lamella were put at the bottom of a 12-well cell culture plate under The IC50 of Glucantime was 221.5 μg/ml after 24 hours. All groups treated with different concentrations of Glucantime showed significant differences with each other and the control group at the tested times (P<0.05). The IC50 of Glucantime was 221.5 μg/ml after 24 hours. All groups treated with different concentrations of Glucantime showed significant differences with each other and the control group at the tested times (P<0.05). The number of amastigotes in all groups treated with different concentrations of A. lappa and Glucantime had significant differences with the control group (P<0.05).
RESULTS
As shown in Figure 2 , different concentrations of the A. lappa extract had potent anti-leishmanial activity against promastigotes. This leishmanicidal effect had a positive correlation with time and concentration in comparison with the control group. The half maximal inhibitory concentration (IC 50 ) of A. lappa extract was 131.25 μg/ml after 24 hours. The survival rate of all groups treated with different concentrations of A. lappa root extract had significant difference from that of control group after 24, 48, and 72 hours (p<0.05). extract of Artemisia seiberi and Artemisinin on L. major showed that the increased concentration of both agents hiegten the reduction rate in the number of parasites. Contrary to our study, their results showed that the effects of both drugs on uninfected and healthy macrophages were little (25) . Another study investigated the effect of Caparis spinose root extract on promastigote and amastigotes of L. major, and found that the anti-protozoal activity of Capris was similar to Glucantime (as a gold standard drug). In the mentioned study, both C. spinose root extract and Glucantime were able to kill 97.8% of promastigotes after 72 hours. C. spinosa and its root extraction have positive effects on amastigote of L. major but at higher concentrations (26) . A study conducted in Mazanderan showed that the extract of Artemisia aucheri inhibited the multiplication of promastigotes at concentrations of 150, 300 and 450 µg/ml after 48 and 72 hours of culture (27) . However, no effect was observed against amastigotes. Nevertheless, the A. lappa extract seemed to be more effective.
CONCLUSION
The results of the present study show the in vitro anti-leishmanial effects of A. lappa methanolic extract against the promastigotes and amastigotes of L. major.
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DISCUSSION
The results of this study showed that the anti-leishmanial effect of A. lappa root methanolic extract and Glucantime is dosedependent, so that an increase in drug dose and duration reduced the parasite's survival rate. Significant differences were observed between all groups and the control group after 24, 48 and 72 hours. The effect of the methanolic extract of A. lappa on amastigotes within macrophages was observed after 24 and 48 hours. The anti-leishmanial effect of A. lappa was observed at concentration of 1000 µg/ml, resulting in a reduction in the number of amastigotes within macrophages. In some studies, the anti-bacterial, anti-fungal, antiviral, anti-inflammatory, antioxidant, and antitumoral effects of A. lappa alcoholic extract have been demonstrated. However, no antileishmanial and anti-parasitic effect have been reported for the A. lappa extract. Several studies investigated the effects of plant extracts on promastigotes and amastigotes of Leishmania. Shirani et al. showed the efficiency of ethanolic extracts of thyme, yarrow and propolis on healing L. major wounds (19) . Suzangar also found that AbuKhesar and yarrow extracts have cytotoxic effects on promastigotes (20) . In another study, Barati showed that the herbal extracts of Shirazi thyme and esfand have antileishmanial effects on the promastigotes of L. major (21) . Asadi 
